Boston Scientific's subcutaneous implantable cardioverter defibrillator proves safe and effective in the 1st real-world data from the EFFORTLESS S-ICD clinical trial.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1fmniZx
Cap comentari:
Publica un comentari a l'entrada